<menu id="wymuy"><strong id="wymuy"></strong></menu>
  • <menu id="wymuy"><strong id="wymuy"></strong></menu> <menu id="wymuy"></menu>
  • <menu id="wymuy"></menu>
  • <input id="wymuy"></input>
  • Scientists, Publishers Debate Paychecks for Peer Reviewers
    Scientists, Publishers Debate Paychecks for Peer Reviewers
    While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.
    Scientists, Publishers Debate Paychecks for Peer Reviewers
    Scientists, Publishers Debate Paychecks for Peer Reviewers

    While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.

    While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.

    research integrity
    UPDATED
    Physician Behind Surgisphere Scandal Switches Medical Licenses
    Physician Behind Surgisphere Scandal Switches Medical Licenses
    Catherine Offord | Oct 23, 2020
    Sapan Desai has inactivated his license in Illinois, where multiple malpractice lawsuits against him are pending, and obtained a new one in Ohio.
    <em>The Lancet&nbsp;</em>Alters Editorial Practices After Surgisphere Scandal
    The Lancet Alters Editorial Practices After Surgisphere Scandal
    Catherine Offord | Sep 22, 2020
    The changes, which affect the declarations authors have to sign and the peer-review process, have received a mixed response from the scientific community.
    Italian Institute Revokes Appointment of Cancer Researcher
    Italian Institute Revokes Appointment of Cancer Researcher
    Catherine Offord | Jul 7, 2020
    Pier Paolo Pandolfi left Harvard University last year following allegations of sexual harassment, and has since been accused of research misconduct.
    Opinion: Don&rsquo;t Disparage the Pace of COVID-19 Research
    Opinion: Don’t Disparage the Pace of COVID-19 Research
    John D. Loike, Salomon Amar | Jun 22, 2020
    Fast science—with all its warts—is making unprecedented progress in the fight against COVID-19.
    Special Report
    Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
    Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
    Catherine Offord | Jun 16, 2020
    The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment. Clinicians there say the effects have been extremely damaging.
    Opinion: Surgisphere Fiasco Highlights Need for Proper QA
    Opinion: Surgisphere Fiasco Highlights Need for Proper QA
    Nadya Gawadi Heywood, David Long | Jun 12, 2020
    Our handbook on best practices for quality assurance in biomedicine can help funding agencies shore up research integrity—which is especially needed at a time when mistakes can have outsize effects.
    Surgisphere Fallout Hits African Nonprofit&rsquo;s COVID-19 Efforts
    Surgisphere Fallout Hits African Nonprofit’s COVID-19 Efforts
    Catherine Offord | Jun 7, 2020
    The company had helped develop a tool to aid decision-making in distributing limited medical equipment among coronavirus patients, but two high-profile retractions call into question the validity of Surgisphere’s work in toto.
    <em>Lancet, NEJM </em>Retract Surgisphere Studies on COVID-19 Patients
    Lancet, NEJM Retract Surgisphere Studies on COVID-19 Patients
    Catherine Offord | Jun 4, 2020
    All authors other than company founder and CEO Sapan Desai were “unable to complete an independent audit of the data,” The Lancet states.
    Concerns Build Over Surgisphere&rsquo;s COVID-19 Dataset
    Concerns Build Over Surgisphere’s COVID-19 Dataset
    Catherine Offord | Jun 2, 2020
    NEJM and The Lancet issue expressions of concern as researchers question where the company got its data on thousands of coronavirus patients.
    精选二四六天天好彩j